Skip to main content

MARSHALL WACE, LLP

Position in RGEN — Repligen Corp

CIK 1318757 LONDON, X0

Position in RGEN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$38,490,678
-$46,116,138 QoQ
Shares Held
282,107
-45.4% QoQ
Ownership
0.500%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#55
of 476 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RGEN Over Time

Shares Held

Position Value (USD)

Position in Medical Instruments & Supplies

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $588,908,935 across 29 Medical Instruments & Supplies names. RGEN ranks #6 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 RGEN
Repligen Corp
This page
282,107 $38,490,678

All Filings in RGEN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,490,678 282,107
2025-12-31 $84,606,816 516,336
2025-09-30 $24,202,689 181,063
2025-06-30 $10,472,174 84,195
2025-03-31 $10,785,880 84,768
2024-12-31 $59,337,104 412,235
2024-09-30 $35,303,378 237,222
2024-06-30 $45,955,299 364,551
2024-03-31 $66,337,553 360,687
2023-12-31 $57,675,704 320,777
2023-09-30 $53,153,703 334,279
2023-06-30 $63,584,572 449,488
2023-03-31 $31,353,513 186,229
2022-12-31 $10,692,095 63,151
2022-09-30 $36,358,279 194,315
2022-06-30 $60,555,224 372,877
2022-03-31 $68,511,217 364,247
2021-12-31 $99,217,802 374,633
2021-09-30 $150,312,368 520,130
2021-06-30 $140,315,692 702,914
2021-03-31 $183,469,382 943,724
2020-12-31 $283,857,686 1,481,280
2020-09-30 $133,918,517 907,676
2020-06-30 $79,495,197 643,113
2020-03-31 $54,497,988 564,512